After a few days, the dose can be increased to around 0.5mg to 1mg per day
Monitoring and Patient Education Strategies Effectively managing rapid glucose improvements with GLP-1 therapy depends heavily on monitoring and patient education
Take our free assessment quiz and start your tailored plan today
Hypoglycemia risk is generally low with Zepbound monotherapy in patients without diabetes, as the medication's insulinotropic effects are glucose-dependent
In addition, RSL3, another ferroptosis inducer, can covalently bind to selenocysteine at the active site of GPX4, thus directly inhibiting the phospholipid peroxidase activity of GPX4 [54]
Further investigations by Moody and Holst indicated that the peptide either was or constituted part of a proglucagon precursor because similar fragments could be found in the pancreas (Moody, Holst, Thim, Lindkaer, Jensen)